| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 58,323 | 56,703 | 56,203 | 59,315 | | Cost of Revenue | 18,484 | 42,621 | 29,266 | 29,743 | | | Gross Profit | 39,839 | 14,082 | 26,937 | 29,572 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 34,528 | 6,767 | 19,079 | 20,373 | | Non Recurring | 7,397 |
-
|
-
|
-
| | Others | 1,718 | 1,903 | 1,799 | 1,438 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (3,804) | 5,412 | 6,059 | 7,761 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 584 | 962 | (481) | 774 | | Earnings Before Interest And Taxes | (3,220) | 6,374 | 5,578 | 8,535 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (3,220) | 6,374 | 5,578 | 8,535 | | Income Tax Expense | (1,104) | 2,186 | 1,673 | 2,705 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (2,116) | 4,188 | 3,905 | 5,830 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (2,116) | 4,188 | 3,905 | 5,830 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($2,116) | $4,188 | $3,905 | $5,830 |
|
0.51% Nasdaq 
Income Statement
